Drug:
Reaction: INJECTION SITE PAIN
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26945437 |
US |
2 | |
Feeling abnormal, Injection site pain, Headache, Pain, Arthralgia, Dizziness, Influenza like illness, Limb discomfort, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, FEXOFENADINE HYDROCHLORIDE, FISH OIL, FLUOXETINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MONTELUKAST SODIUM, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, ERGOCALCIFEROL, TIOTROPIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 102 | 26945453 |
US |
76 | 2 |
Limb discomfort, Brain fog, Arthralgia, Injection site haemorrhage, Pain in extremity, Injection site pain, |
||||
ABALOPARATIDE, VITAMIN C, ERGOCALCIFEROL, PSYLLIUM HUSK, SIMVASTATIN, AMLODIPINE BESYLATE, |
||||
| 103 | 26945467 |
US |
23 | 1 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 104 | 26945498 |
US |
2 | |
Feeling of body temperature change, Burning sensation, Fatigue, Nausea, Abdominal pain, Pruritus, Headache, Arthralgia, Bone pain, Arthralgia, Pruritus, Injection site swelling, Injection site pain, Injection site haemorrhage, Ocular discomfort, Dizziness, Product packaging issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, POTASSIUM CHLORIDE, PANTOPRAZOLE, PROMETHAZINE HYDROCHLORIDE, TIZANIDINE, CYANOCOBALAMIN, |
||||
| 105 | 26945603 |
US |
||
Injection site pain, Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 106 | 26945610 |
US |
2 | |
Urticaria, Heart rate irregular, Condition aggravated, Injection site pain, Tachycardia, Pruritus, Heart rate increased, Dizziness, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 107 | 26945621 |
US |
1 | |
Injection site irritation, Injection site pain, Injection site bruising, Injection site swelling, Injection site erythema, Injection site reaction, |
||||
ABALOPARATIDE, |
||||
| 108 | 26945775 |
US |
2 | |
Injection site discomfort, Depression, Anxiety, Injection site pain, Diarrhoea, Insomnia, |
||||
ABALOPARATIDE, MAGNESIUM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 109 | 26945797 |
US |
2 | |
Balance disorder, Heart rate increased, Injection site pain, Dizziness, Bone pain, Arthralgia, Off label use, |
||||
ABALOPARATIDE, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, AZELASTINE, CALCIUM, FLUTICASONE PROPIONATE, MOMETASONE, MONTELUKAST SODIUM, TERIPARATIDE, |
||||
| 110 | 26945843 |
US |
67 | 2 |
Flushing, Mouth swelling, Local reaction, Erythema, Papule, Injection site pain, Injection site erythema, Pruritus, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 111 | 26945884 |
US |
63 | 2 |
Injection site irritation, Bone disorder, Muscle discomfort, Nasopharyngitis, Feeling abnormal, Injection site erythema, Injection site bruising, Back pain, Dyspnoea, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 112 | 26945897 |
US |
68 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 113 | 26945950 |
US |
58 | 2 |
Blood pressure increased, Neck pain, Injection site pain, Heart rate increased, Dizziness, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 114 | 26945959 |
US |
2 | |
Feeling jittery, Injection site pruritus, Injection site erythema, Injection site swelling, Headache, Heart rate increased, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 115 | 26946049 |
US |
82 | 2 |
Somnolence, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 116 | 26946055 |
US |
2 | |
Flatulence, Blood pressure increased, Dizziness, Palpitations, Abdominal distension, Injection site pain, Injection site bruising, Headache, Muscle spasms, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 117 | 26946076 |
US |
2 | |
Decreased appetite, Nausea, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 118 | 26946083 |
US |
67 | 2 |
Body dysmorphic disorder, Rib deformity, Weight decreased, Peripheral swelling, Pain, Injection site pain, Injection site haemorrhage, Product dose omission in error, |
||||
ABALOPARATIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, BUSPIRONE HYDROCHLORIDE, CYANOCOBALAMIN, DEXTROAMPHETAMINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, GABAPENTIN, IRON, LORAZEPAM, METHOCARBAMOL, METHOCARBAMOL TABLETS, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), MIRTAZAPINE, MOMETASONE FUROATE, MOMETASONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, PANTOPRAZOLE, TRETINOIN, TAVABOROLE, TAVABOROLE TOPICAL SOLUTION, 5%, TOPIRAMATE, ERGOCALCIFEROL, |
||||
| 119 | 26946085 |
US |
66 | 2 |
Hypoglycaemia, Visual impairment, Muscular weakness, Muscle contractions involuntary, Migraine, Memory impairment, Eyelid ptosis, Dyspnoea, Neck pain, Headache, Heart rate increased, Injection site pain, Injection site bruising, Bone pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, MUPIROCIN, MUPIROCIN CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FEXOFENADINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ONABOTULINUMTOXINA, ONDANSETRON HYDROCHLORIDE, MELATONIN, ZOLPIDEM TARTRATE, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, CARISOPRODOL, GABAPENTIN, FAMOTIDINE, CIPROFLOXACIN HYDROCHLORIDE, |
||||
| 120 | 26946172 |
US |
2 | |
Myalgia, Nausea, Bone pain, Injection site pain, Arthralgia, Dizziness, Headache, Product dose omission issue, Product administration interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, MAGNESIUM, |
||||
| 121 | 26946188 |
US |
2 | |
Fear of injection, Musculoskeletal stiffness, Neck pain, Sleep disorder, Injection site pain, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 122 | 26946189 |
US |
66 | 2 |
Injection site nodule, Feeling abnormal, Headache, Fatigue, Nausea, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 123 | 26946193 |
US |
66 | 2 |
Dry mouth, Paraesthesia, Injection site pain, Back pain, Fatigue, Muscle spasms, |
||||
ABALOPARATIDE, |
||||
| 124 | 26946200 |
US |
62 | 2 |
Rash papular, Injection site erythema, Pruritus, Headache, Injection site pain, Needle issue, |
||||
ABALOPARATIDE, PREDNISONE, |
||||
| 125 | 26946241 |
US |
2 | |
Injection site bruising, Injection site pain, Dizziness, Pain, Limb discomfort, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 126 | 26946248 |
US |
1 | |
Neck pain, Tension headache, Musculoskeletal stiffness, Urticaria, Muscular weakness, Rib fracture, Injection site pain, Fatigue, Pain in extremity, Bone pain, Arthralgia, Product dose omission issue, Needle issue, Product use complaint, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ACYCLOVIR, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, PROCHLORPERAZINE, RITUXIMAB, |
||||
| 127 | 26946255 |
US |
2 | |
Cervical radiculopathy, Lumbar radiculopathy, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 128 | 26946259 |
US |
2 | |
Injection site haematoma, Injection site bruising, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 129 | 26946280 |
US |
2 | |
Injection site pain, Injection site erythema, Injection site bruising, Injection site haematoma, Adverse drug reaction, Fear of injection, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 130 | 26946298 |
US |
2 | |
Heart rate increased, Palpitations, Injection site pain, Pain, Fatigue, Hypersensitivity, Skin striae, |
||||
ABALOPARATIDE, |
||||
| 131 | 26946326 |
US |
10 | 1 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 132 | 26946345 |
US |
2 | |
Injection site discomfort, Sensitive skin, Injection site pain, Wrong technique in product usage process, |
||||
ABALOPARATIDE, LEVOTHYROXINE SODIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, MELOXICAM, HYDROCHLOROTHIAZIDE, SERTRALINE HYDROCHLORIDE, PENICILLIN V POTASSIUM, |
||||
| 133 | 26946347 |
US |
2 | |
Visual impairment, Injection site pain, Headache, Insomnia, Fatigue, Bone pain, Pain, Drug hypersensitivity, Product dose omission in error, Device defective, Device physical property issue, Drug dose omission by device, Needle issue, Product communication issue, Injury associated with device, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 134 | 26946351 |
US |
2 | |
Body temperature increased, Musculoskeletal discomfort, Injection site pain, Heart rate increased, Dizziness, Bone pain, Insomnia, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 135 | 26946369 |
US |
84 | 2 |
Injection site pain, Injection site reaction, Fatigue, Device malfunction, Drug dose omission by device, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 136 | 26946372 |
US |
2 | |
Myalgia, Tremor, Injection site nodule, Feeling abnormal, Palpitations, Fatigue, Headache, Arthralgia, Dizziness, Injection site pain, Product administration error, |
||||
ABALOPARATIDE, ABALOPARATIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE, LORATADINE, LORATADINE TABLET, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 137 | 26946384 |
US |
2 | |
Flushing, Hyperhidrosis, Irritable bowel syndrome, Decreased appetite, Nausea, Headache, Injection site pain, Fatigue, Asthenia, Malaise, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TIRZEPATIDE, |
||||
| 138 | 26946385 |
US |
61 | 2 |
Injection site pain, Device defective, Device failure, Wrong technique in product usage process, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 139 | 26946411 |
US |
77 | 2 |
Movement disorder, Dizziness, Injection site pain, Nausea, |
||||
ABALOPARATIDE, MEPOLIZUMAB, PREDNISONE, MAGNESIUM, ERGOCALCIFEROL, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, PITAVASTATIN CALCIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, TIOTROPIUM BROMIDE, |
||||
| 140 | 26946413 |
US |
2 | |
Spinal laminectomy, Dysarthria, Procedural pain, Hyperhidrosis, Injection site bruising, Injection site pain, Palpitations, Pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, GABAPENTIN, PREGABALIN, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, THYROID, PORCINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, BIOTIN, BUPROPION HYDROCHLORIDE, CALCIUM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, FOLIC ACID, IBANDRONATE SODIUM, MAGNESIUM CHLORIDE, MONTELUKAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, SELENIUM, VITAMIN C, |
||||
| 141 | 26946454 |
US |
61 | 2 |
Dizziness postural, Asthenopia, Lacrimation increased, Injection site pain, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 142 | 26946461 |
US |
1 | |
Injection site pain, Device mechanical issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 143 | 26946477 |
US |
2 | |
Morning sickness, Nausea, Headache, Injection site pain, Heart rate increased, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 144 | 26946507 |
US |
71 | 2 |
Muscular weakness, Injection site pain, Injection site bruising, Product use complaint, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 145 | 26946536 |
US |
2 | |
Injection site bruising, Injection site pain, Device defective, Product use in unapproved indication, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 146 | 26946636 |
US |
2 | |
Injection site irritation, Musculoskeletal stiffness, Burning sensation, Fear of injection, Myalgia, Dizziness, Injection site pain, Product storage error, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, ROSUVASTATIN, ACETAMINOPHEN, |
||||
| 147 | 26946683 |
US |
2 | |
Dysgeusia, Injection site pain, Wrong technique in product usage process, |
||||
ABALOPARATIDE, |
||||
| 148 | 26946748 |
US |
68 | 1 |
Injection site bruising, Injection site reaction, Injection site pain, Device issue, Injection site rash, |
||||
ADALIMUMAB, |
||||
| 149 | 26946751 |
US |
48 | 2 |
Injection site urticaria, Injection site pain, Injection site bruising, Product contamination physical, Liquid product physical issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 150 | 26946766 |
US |
2 | |
Feeding disorder, Illness, Injection site discharge, Abdominal discomfort, Headache, Nausea, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 151 | 26946810 |
US |
2 | |
Migraine, Nausea, Injection site pain, Headache, Palpitations, Injection site bruising, Injection site pruritus, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 152 | 26946863 |
US |
2 | |
Blood pressure decreased, Palpitations, Heart rate increased, Injection site pain, Back pain, Pain in extremity, Arthralgia, Wrong technique in device usage process, |
||||
ABALOPARATIDE, |
||||
| 153 | 26946864 |
US |
65 | 2 |
Cold sweat, Injection site pruritus, Injection site bruising, Palpitations, Headache, Bone pain, Muscle spasms, Injection site pain, Intentional product use issue, Device leakage, Product dispensing issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 154 | 26946871 |
US |
2 | |
Injection site scar, Injection site streaking, Injection site pain, |
||||
ABALOPARATIDE, PREDNISONE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SOTALOL HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 155 | 26946898 |
US |
2 | |
Spinal pain, Spinal pain, Gait disturbance, Dyspepsia, Feeling abnormal, Fatigue, Injection site pain, Abdominal pain upper, Incorrect dose administered, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 156 | 26946931 |
US |
2 | |
Migraine, Dizziness, Nausea, Injection site pain, Vertigo, Bone pain, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 157 | 26946948 |
US |
68 | 2 |
Unevaluable event, Fatigue, Injection site pain, Injection site pruritus, Palpitations, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 158 | 26946949 |
US |
2 | |
Genital rash, Rash pruritic, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 159 | 26946981 |
US |
2 | |
Thirst, Pollakiuria, Headache, Nausea, Arthralgia, Dizziness, Heart rate increased, Injection site pain, Abdominal pain upper, |
||||
ABALOPARATIDE, |
||||
| 160 | 26946987 |
US |
63 | 2 |
Injection site induration, Injection site pain, Injection site swelling, |
||||
ABALOPARATIDE, LOSARTAN POTASSIUM, LOSARTAN, CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE HYDROCHLORIDE, AMLODIPINE BESYLATE, ERGOCALCIFEROL, PREGABALIN, |
||||
| 161 | 26947002 |
US |
2 | |
Gastrooesophageal reflux disease, Dizziness, Nausea, Abdominal distension, Injection site pain, Injection site haemorrhage, |
||||
ABALOPARATIDE, |
||||
| 162 | 26947019 |
US |
75 | 2 |
Injection site pain, Injection site swelling, Product packaging quantity issue, Device mechanical issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 163 | 26947032 |
US |
64 | 2 |
Blood pressure increased, Headache, Injection site pain, |
||||
ABALOPARATIDE, GABAPENTIN, VALSARTAN, VALSARTAN ORAL, |
||||
| 164 | 26947075 |
US |
2 | |
Injection site discomfort, Stress, Injection site pain, Product temperature excursion issue, |
||||
ABALOPARATIDE, |
||||
| 165 | 26947162 |
US |
2 | |
Injection site discolouration, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 166 | 26947165 |
US |
68 | 2 |
Migraine prodrome, Injection site bruising, Injection site pain, |
||||
ABALOPARATIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, BIOTIN, BUDESONIDE, CALCIUM, CHOLESTYRAMINE, EZETIMIBE, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), RIZATRIPTAN, SERTRALINE HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, CYANOCOBALAMIN, ERGOCALCIFEROL, |
||||
| 167 | 26947169 |
US |
70 | 2 |
Migraine, Injection site bruising, Injection site pain, Abdominal pain, Muscle spasms, Headache, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 168 | 26947174 |
US |
2 | |
Middle insomnia, Dizziness, Fatigue, Injection site haemorrhage, Injection site swelling, Injection site pain, Wrong technique in device usage process, |
||||
ABALOPARATIDE, |
||||
| 169 | 26947189 |
US |
2 | |
Nasopharyngitis, Pharyngitis streptococcal, Headache, Nausea, Pain in extremity, Back pain, Dizziness, Vertigo, Heart rate increased, Abdominal pain upper, Injection site pain, Injection site bruising, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, MAGNESIUM, MELOXICAM, CYANOCOBALAMIN, ALPRAZOLAM, |
||||
| 170 | 26947202 |
US |
76 | 2 |
Weight increased, Injection site pain, Injection site bruising, |
||||
ABALOPARATIDE, ERGOCALCIFEROL, RISANKIZUMAB-RZAA, LOSARTAN POTASSIUM, LOSARTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 171 | 26947205 |
US |
2 | |
Somnolence, Arthralgia, Dizziness, Diarrhoea, Fatigue, Headache, Nausea, Abdominal pain upper, Injection site bruising, Injection site pain, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, BACLOFEN, PREGABALIN, MAGNESIUM, MELOXICAM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ALBUTEROL SULFATE, ERGOCALCIFEROL, |
||||
| 172 | 26947217 |
US |
78 | 2 |
Injection site pain, Nausea, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 173 | 26947227 |
US |
2 | |
Brain fog, Feeling abnormal, Headache, Palpitations, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 174 | 26947241 |
US |
2 | |
Back pain, Abdominal pain, Injection site pain, Bone pain, Product dose omission in error, Wrong technique in device usage process, |
||||
ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CALCIUM, |
||||
| 175 | 26947248 |
US |
2 | |
Injection site discomfort, Weight increased, Stress, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 176 | 26947251 |
US |
2 | |
Injection site urticaria, Eye pruritus, Hypersensitivity, Injection site pruritus, Injection site erythema, Pain, Injection site pain, Injection site rash, |
||||
ABALOPARATIDE, ABALOPARATIDE, ERGOCALCIFEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 177 | 26947276 |
US |
50 | 1 |
Injection site pain, Injection site warmth, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 178 | 26947298 |
US |
2 | |
Injection site vesicles, Injection site pain, Dizziness, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 179 | 26947299 |
US |
2 | |
Infection, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, CALCIUM, CEVIMELINE HYDROCHLORIDE, CEVIMELINE, CYCLOSPORINE, ERYTHROMYCIN, MELOXICAM, PERFLUOROHEXYLOCTANE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, ERGOCALCIFEROL, |
||||
| 180 | 26947335 |
US |
2 | |
Carpal tunnel decompression, Illness, Injection site pain, Nausea, Pruritus, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, GABAPENTIN, GABAPENTIN, IRON, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DIAZEPAM, VITAMIN C, OXYBUTYNIN, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 181 | 26947338 |
US |
2 | |
Headache, Injection site pain, Therapeutic response unexpected, |
||||
ABALOPARATIDE, |
||||
| 182 | 26947339 |
US |
30 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 183 | 26947369 |
US |
2 | |
Vertebroplasty, Heart rate irregular, Weight decreased, Diarrhoea, Injection site bruising, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, GABAPENTIN, PRAMIPEXOLE DIHYDROCHLORIDE, TREPROSTINIL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, VITAMIN C, ERGOCALCIFEROL, BIOTIN, QUETIAPINE, METHOCARBAMOL, METHOCARBAMOL TABLETS, RABEPRAZOLE SODIUM, LITHIUM CARBONATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MACITENTAN, ESTRADIOL, DIPHENHYDRAMINE HYDROCHLORIDE, FENOFIBRATE, DIVALPROEX SODIUM, BUMETANIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIVALPROEX SODIUM, ERGOCALCIFEROL, ACETAMINOPHEN, OXYGEN, 0XYGEN, GABAPENTIN ENACARBIL, |
||||
| 184 | 26947380 |
US |
2 | |
Abdominal discomfort, Nausea, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 185 | 26947402 |
US |
83 | 2 |
Feeling abnormal, Bone pain, Arthralgia, Pain, Injection site pain, Fatigue, Therapeutic response unexpected, |
||||
ABALOPARATIDE, |
||||
| 186 | 26947492 |
US |
2 | |
Weight increased, Dizziness, Bone pain, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 187 | 26947532 |
US |
36 | 2 |
Skin irritation, Injection site pain, Device mechanical issue, Product use issue, Drug dose omission by device, Incorrect dose administered by device, Product use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 188 | 26947644 |
US |
59 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 189 | 26947707 |
US |
2 | |
Abdominal rigidity, Gastrointestinal disorder, Abdominal distension, Injection site pain, Injection site bruising, Injection site swelling, Injection site erythema, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 190 | 26947711 |
US |
1 | |
Memory impairment, Injection site pain, Product dose omission in error, Product administered at inappropriate site, |
||||
ABALOPARATIDE, |
||||
| 191 | 26947718 |
US |
2 | |
Influenza, Anaemia, Vitamin D increased, Injection site erythema, Injection site bruising, Injection site pain, Blood calcium increased, |
||||
ABALOPARATIDE, OLOPATADINE HYDROCHLORIDE, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, BUDESONIDE, CALCIUM, BIOTIN, MAGNESIUM, CETIRIZINE HCL, CETIRIZINE, ERGOCALCIFEROL, |
||||
| 192 | 26947735 |
US |
2 | |
Arthritis, Myalgia, Diplopia, Vision blurred, Pain in extremity, Injection site pruritus, Headache, Injection site pain, Bone pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN CALCIUM, MAGNESIUM, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, VITAMIN C, CALCIUM, |
||||
| 193 | 26947742 |
US |
2 | |
Skin burning sensation, Arthralgia, Bone pain, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 194 | 26947755 |
US |
2 | |
Injection site pain, Device delivery system issue, |
||||
ABALOPARATIDE, |
||||
| 195 | 26947758 |
US |
2 | |
Rash, Injection site pain, |
||||
RAVULIZUMAB, |
||||
| 196 | 26947843 |
US |
2 | |
Blood pressure systolic increased, Bone pain, Headache, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 197 | 26947855 |
US |
2 | |
Injection site pain, Injection site haemorrhage, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 198 | 26947873 |
US |
2 | |
Paraesthesia, Sleep disorder, Contusion, Nausea, Dizziness, Pain, Injection site pain, Product administration error, Product use in unapproved indication, |
||||
ABALOPARATIDE, CALCIUM, MAGNESIUM, |
||||
| 199 | 26947888 |
US |
64 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 200 | 26947955 |
US |
13 | 2 |
Injection site pain, Pruritus, Skin fissures, Skin haemorrhage, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30